Drug Survival of Omalizumab in Patients With Chronic Urticaria and the Potential Predictors for Discontinuation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation
JAMA Dermatol 2024 Jul 17;[EPub Ahead of Print], R Soegiharto, M Alizadeh Aghdam, JA Sørensen, E van Lindonk, F Bulut Demir, NM Porras, Y Matsuo, L Kiefer, AC Knulst, M Maurer, C Ritchie, M Rudenko, E Kocatürk, RFJ Criado, S Gregoriou, T Bobylev, A Kleinheinz, S Takahagi, M Hide, AM Giménez-Arnau, A Salman, RO Kara, B Sevimli Dikicier, MBA van Doorn, SF Thomsen, JMPA van den Reek, H RöckmannFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.